Please ensure Javascript is enabled for purposes of website accessibility

Search

15,186 Results for "👉 acc6.top 👈🏻 buy a subscription Telegram account"
15,186 Results for "👉 acc6.top 👈🏻 buy a subscription Telegram account".
  • What the New Inflation Reduction Act Means for Greentech Stocks

  • Is Gold on the Brink of a Big Comeback?

  • What the Chips Act Means for Semiconductor Stocks

  • The Best States in America to Find a Job Today

  • Investigating 2 Beaten-Down Retail Stocks

  • 3 Important Lessons Learned from this Little-Known Guru

  • This Bullish Signal Means You Should Start Buying Stocks Again

  • An SaaS Stock to Buy for the Long Haul

  • How to Win 80% of Your Options Trades

  • 3 Small-Time Financial Stocks with Big-Time Potential
  • Looking at the broad market we see that the S&P 500 is just 4% off its recent high, has thus far held above support around 2,800 and remains above its long-term (200-day) moving average line. The Nasdaq dipped to its May 13 low near 7,627, but it too is above its long-term moving average line.
  • Market leadership appears to be shifting. It’s interesting to note that utilities have been the top performing market sector over the past month and week.
  • It’s all about the Fed today. The woefully behind-the-curve Central Bank will announce another Fed Funds rate hike today. The increase is widely expected to be another 0.75%. But some worry it could be 1.00%.

    The market’s hopes were dashed when August inflation was worse than expected. That means the Fed will have to continue to be hawkish and for a while longer. Plus, after four rate hikes so far, two straight quarters of GDP contraction, and a bear market; inflation isn’t budging yet.
  • The cannabis sector has a dream ticket with Kamala Harris and Tim Walz. Investors act like they haven’t even noticed. This seems like a big mistake.

    The key takeaway: Cannabis stocks look buyable in the current bout of dramatic sector weakness. Cannabis investors are notoriously bipolar. Right now, they are in a dark mood. That’s usually been the best time to add to positions, especially when there are potential catalysts on the horizon like now. In today’s update, I outline the main ones and the possible timing.
  • Tariff uncertainty is back. But this time it’s just keeping stocks from going higher, not dragging the market lower.

    The administration is currently threatening to enforce 30% tariffs on Mexico and the European Union (EU) starting on August 1. However, investors perceive a strong chance that President Trump will either back off the threat or make deals. Meanwhile, the S&P 500 continues to hover right near the high.
  • The stock market has begun to recover from last week’s war of words-induced selloff, and I’m moving one stock back to Buy today. However, it’s not time for the all-clear yet; last week’s selloff was preceded by significant deterioration under the surface of the market, so we’ll need to see more proof that the bulls are back before jumping back in the water.
  • Small-cap discretionary, energy, financials, industrials, technology and materials are all moving higher. That’s a healthy mix, and it’s helped push the S&P 600 Small Cap Index back up near overhead resistance.

  • The major indexes have mostly moved sideways since our last update, but volatility remains high. The past week also brought a slew of earnings reports, and some big reactions, so I have three rating changes today.
  • While today brings an unexpected new political reality, markets around the world are already adjusting to the new order.
  • With so much going on in the world the trends are a bit messy. That said, I have noticed an uptick in several of the small-cap MedTech players on my watch list.

    These businesses could be poised for a nice recovery in 2022 and 2023 as COVID-19 recedes. And the one that tops my list is posting massive growth as its revolutionary treatment for BPH has just gained full Medicare backing and is rolling out into U.S. hospitals.



    With revenue set to grow by multiples in the coming years and the stock trading at an apparent steep discount to peers, we’ll jump in now.



    Enjoy!


  • Market Gauge is 5Current Market Outlook


    After last Monday’s plunge, the initial rebound was very encouraging, and the fact that the major indexes are still doing their best to hang in there is a plus. But, while many individual stocks are in decent shape, the wild rotation that has been a hallmark of 2021 has returned, with money racing into cyclical areas and out of growth stocks the past couple of days. We’re still sticking with a stock-by-stock approach, and most names, despite their wobbles, remain in fine shape, simply pulling in after big runs; others, however, look worse and should be pared back or sold. To be fair, such action isn’t totally surprising—big breaks like last Monday’s usually have some reverberations, so we wouldn’t say the action is negative as much as it’s a sign we’re still in the tricky, choppy environment that has existed for some time. We’re going to leave the Market Monitor at a level 5 and see how things play out in the days ahead.

    The good news is that this week’s list is full of names that have enjoyed outsized accumulation of late. Our Top Pick is Devon Energy (DVN), which looks like a leader of a fresh breakout in energy stocks (and cyclical stocks more broadly). We suggest aiming for dips as these names usually pull in after powerful rallies.
    Stock NamePriceBuy RangeLoss Limit
    Apache (APA) 2322-23.519.5-20
    Biohaven Pharmaceutical Holding (BHVN) 133130-134116-119
    Brooks Automation, Inc. (BRKS) 109102-10693-95
    Cimarex Energy (XEC) 8882-8572.5-74.5
    Devon Energy (DVN) 3532-3428.5-29.5
    DoorDash (DASH) 217206-212185-189
    SeaWorld Entertainment Inc. (SEAS) 5856.5-58.551.5-52.5
    Signet Jewelers (SIG) 8482-8573-75
    Snap Inc. (SNAP) 8078-8169-71
    SVB Financial Group (SIVB) 674655-675600-610

  • The bullish start to 2023 has many investors optimistic that we’ve avoided the Fed’s “hard landing” scenario. Here are two stocks that can do well in either case.
  • Utility stocks have been the worst performers this year due to factors that are likely to abate soon. These two stocks are poised to benefit.
  • Dividend stocks outperformed the broader market in 2022, and they’re an especially important addition to your portfolio in bear markets like the one we’ve got now.
  • Dividend stocks are always a wise safety net for any portfolio. But right now, they’re essential market beaters. Here are two we like.